-
Risk as a catalyst: PwC’s Tiffany Gallagher on healthcare compliance innovation
How rapid tech advance has changed healthcare’s compliance landscape.
-
GRIP Extra: SEC Commissioner cautions against rapid deregulation, Greenpeace held liable for $650m
Other news includes the SEC ceasing its defenses of its climate disclosure rule, Fidelity launching its own stablecoin, and UBS limiting its size to skirt capital requirements.
-
Conflicts of interest in healthcare: Aaron Narva explains the tech and the processes
He talks about his AI-powered, data-driven platform and why better management of conflicts of interest can eradicate fraud and overspend.
-
Celito Tech’s Ravi Monangi and Ethan Grammer on compliant growth in life science
We explored how small and mid-sized pharmaceutical and biotech companies can avoid costly early compliance mistakes and minimize risk as they scale.
-
India must regulate to safeguard its reputation as “the world’s pharmacy”
Last year, India’s pharmaceutical industry had an annual turnover of around $65 billion. But there is potential for far greater revenue.
-
Regulatory uncertainty brings risk and opportunity to pharma in 2025, says Jeff Lemay
CCO Jeff Lemay reflects on his time at Jazz Pharmaceuticals and asseses the road ahead for compliance and legal teams in the pharma sector.
-
New UK competition rules to affect global deal reviews for tech and pharma
The pharma industry has been the focus of recent competition investigations in the UK, EU and US.
-
UK pharma giant GSK suspends DEI initiatives citing US policy
Internal comms emphasize the fact that the US is the firm’s largest market.